COVID-19 Impact on Global Conjunctivitis Treatment Market: By Disease Type (Allergic Conjunctivitis, Bacterial Conjunctivitis and Viral Conjunctivitis); By End User (Ointment, Drugs and Drops) and Region –Analysis of Market Size, Share and Trends for 2014 – 2020 and Forecasts to 2030

May 2022 | 281 pages | ID: C99896C7BDFAEN
Fatpos Global

Abstracts

COVID-19 Impact on Global Conjunctivitis Treatment Market: By Disease Type (Allergic Conjunctivitis, Bacterial Conjunctivitis and Viral Conjunctivitis); By End User (Ointment, Drugs and Drops) and Region –Analysis of Market Size, Share and Trends for 2014 – 2020 and Forecasts to 2030

Contents

1. EXECUTIVE SUMMARY

2. CONJUNCTIVITIS TREATMENT MARKET

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. AVERAGE PRICING ANALYSIS

5. MARKET DYNAMICS

5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends

6. CORRELATION & REGRESSION ANALYSIS

6.1. Correlation Matrix
6.2. Regression Matrix

7. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

8. RISK ANALYSIS

8.1. Demand Risk Analysis
8.2. Supply Risk Analysis

9. CONJUNCTIVITIS TREATMENT MARKET ANALYSIS

9.1. Porters Five Forces
  9.1.1. Threat of New Entrants
  9.1.2. Bargaining Power of Suppliers
  9.1.3. Threat of Substitutes
  9.1.4. Rivalry
9.2. PEST Analysis
  9.2.1. Political
  9.2.2. Economic
  9.2.3. Social
  9.2.4. Technological

10. CONJUNCTIVITIS TREATMENT MARKET

10.1. Market Size & forecast, 2019A-2030F
  10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

11. CONJUNCTIVITIS TREATMENT MARKET: MARKET SEGMENTATION

11.1. By Regions
  11.1.1. North America:(U.S. and Canada)
    11.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  11.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
    11.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  11.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
    11.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  11.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
    11.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  11.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
    11.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12. CONJUNCTIVITIS TREATMENT MARKET: MARKET SEGMENTATION

12.1. By disease type: Market Share (2020-2030F)
  12.1.1. Allergic conjunctivitis, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12.1.2. Bacterial conjunctivitis, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12.1.3. Viral conjunctivitis, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By formulation type : Market Share (2020-2030F)
  12.2.1. ointment, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12.2.2. drugs, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12.2.3. drops, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

13. COMPANY PROFILE

13.1. Novartis AG
  13.1.1. Company Overview
  13.1.2. Company Total Revenue (Financials)
  13.1.3. Market Potential
  13.1.4. Global Presence
  13.1.5. Key Performance Indicators
  13.1.6. SWOT Analysis
  13.1.7. Product Launch
13.2. Bausch & Lomb Incorporated
13.3. Allergan Plc
13.4. NicOx S.A.
13.5. Alembic Pharmaceuticals
13.6. Sanofi S.A.
13.7. Pfizer Inc.
13.8. Other prominent players
Consultant Recommendation
**The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.